Environmental enteropathy

Uses your system voice; voice and rate in settings.

Snapshot

≈ 8 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Environmental enteropathy (EE or tropical enteropathy or environmental enteric dysfunction or EED) is an acquired small intestinal disorder characterized by gut inflammation, reduced absorptive surface area in small intestine, and disruption of intestinal barrier function. EE is most common amongst children living in low-resource settings. Acute symptoms are typically minimal or absent.

EE can lead to malnutrition, anemia (iron-deficiency anemia and anemia of chronic inflammation), stunted growth, impaired brain development, and impaired response to oral vaccinations. The cause of EE is multifactorial. Overall, exposure to contaminated food and water leads to a generalized state of intestinal inflammation.

The inflammatory response results in multiple pathological changes to the gastrointestinal tract: Smaller villi, larger crypts (called crypt hyperplasia), increased permeability, and inflammatory cell build-up within the intestines. These changes result in poor absorption of food, vitamins and minerals. Standardized, clinically practical diagnostic criteria do not exist.

The most accurate diagnostic test is intestinal biopsy. However, this test is invasive and unnecessary for most patients. Prevention is the strongest and most reliable option for preventing EE and its effects.

Therefore, prevention and treatment of EE are often discussed together.

Environmental enteropathy (EE or tropical enteropathy or environmental enteric dysfunction or EED) is an acquired small intestinal disorder characterized by gut inflammation, reduced absorptive surface area in small intestine, and disruption of intestinal barrier function. EE is most common amongst children living in low-resource settings. Acute symptoms are typically minimal or absent.

EE can lead to malnutrition, anemia (iron-deficiency anemia and anemia of chronic inflammation), stunted growth, impaired brain development, and impaired response to oral vaccinations. The cause of EE is multifactorial. Overall, exposure to contaminated food and water leads to a generalized state of intestinal inflammation.

The inflammatory response results in multiple pathological changes to the gastrointestinal tract: Smaller villi, larger crypts (called crypt hyperplasia), increased permeability, and inflammatory cell build-up within the intestines. These changes result in poor absorption of food, vitamins and minerals. Standardized, clinically practical diagnostic criteria do not exist.

The most accurate diagnostic test is intestinal biopsy. However, this test is invasive and unnecessary for most patients. Prevention is the strongest and most reliable option for preventing EE and its effects.

Therefore, prevention and treatment of EE are often discussed together.

Long-term symptoms

Malnutrition EE causes malnutrition by way of both malabsorption and nutritional deficiencies. Growth and physical development The first two years (and the prior 9 months of fetal life) are critical for linear growth. Stunting is an easy to measure symptom of these child development deficits.

Neurocognitive (brain development) Effect on oral vaccination Many oral vaccines, both live and non-living, have proven to be less immunogenic or less protective when administered to infants, children or adults living in low socioeconomic conditions in developing countries than they are when used in industrialized countries. Widespread EE is hypothesized to be a contributing cause for this observation.

Causes

The development of environmental enteropathy (EE) is multifactorial, but predominantly associated with chronic exposure to contaminated food and water. This is especially true in environments where widespread open defecation and lack of sanitation are common. The main cause of environmental enteropathy is likely repeated exposure to enteric pathogens through fecal contamination.

Rotavirus, norovirus, cryptosporidium, shigella, campylobacter and E-coli are among the most prevalent causative agents.

Mechanism

Long-term exposure to environmental pathogens leads to a generalized state of intestinal inflammation. Chronic inflammation leads to both functional and structural changes which alter gut permeability and ability of the intestine to absorb nutrients.

Specifically, structural changes within the intestine include smaller villi, larger crypts (called crypt hyperplasia), increased permeability, and inflammatory cell build-up within the intestines. These changes result in poor absorption of food, vitamins and minerals – or "modest malabsorption".

Diagnosis

The current gold standard diagnostic test for EE is intestinal biopsy and histological analysis. Histological changes observed include: Villous blunting Crypt hypertrophy Villous fusion Mucosal inflammation The key histological features are villous flattening, crypt hyperplasia and inflammation in the epithelium and lamina propria.

However, this procedure is considered too invasive, complex and expensive to be implemented as standard of care. As a result, there are various research efforts underway to identify biomarkers associated with EE, which could serve as less invasive, yet representative, tools to screen for and identify EE from stool samples.

In an effort to identify simple, accurate diagnostic tests for EE, the Bill and Melinda Gates Foundation (BMGF) has established an EE biomarkers consortium as part of their Global Grand Challenges initiative (specifically, the Discover Biomarkers of Gut Function challenge). So far, various biomarkers have been selected and studied based on the current understanding of EE pathophysiology: Gut permeability/barrier function Dual sugar permeability (lactose-to-mannitol ratio) Intestinal inflammation Alpha-1 anti-trypsin Neopterin Myeloperoxidase Exocrine (hormonal) markers Bacterial translocation markers Endotoxin core antibody Markers of systemic inflammation Alpha-1 glycoprotein C-reactive protein (CRP)  It is postulated that the limited of understanding of EE is partially due to the paucity of reliable biomarkers, making it difficult for researchers to track the epidemiology of the condition and assess the efficacy of interventions.

EE is described as a reversible condition which is probabilistically associated with poor development, but is neither a necessary nor a sufficient cause and may lead to no observable clinical outcomes. This contributes to difficulties encountered when assessing EE.

Prevention

Prevention focuses on improving access to improved water, sanitation and hygiene (WASH). Another important factor responsible for EE is contaminated soil in child play spaces, often caused by the presence of livestock such as chicken in the household. Creating a clean play space might therefore be an effective preventive measure for EE in toddlers.

Some potential strategies to prevent EE are: Improve Water, Sanitation and Hygiene practice both at individual and household levels Reduce faecal contamination of food and water Limit exposure to livestock and poultry

Treatment

There is no effective and accepted treatment for EE. Treatment focuses on addressing the central components of intestinal inflammation, bacterial overgrowth and nutritional supplementation.

Some potential interventions to improve symptoms associated with EE are: Exclusive breastfeeding Improve dietary diversity Use of prebiotics, probiotics, and synbiotics Dietary interventions such as egg and milk Multiple micronutrient supplements Supplementation with lactoferrin and lysozyme Antimicrobials in the context of acute malnutrition and infection The role of nutrition in environmental enteropathy is increasingly being recognized. Environmental enteropathy is likely associated with energy deficiency and underweight.

Mice fed a moderately energy- and protein deficient diet who are exposed to intestinal pathogens show traits similar to environmental enteropathy. Further, weight gain in malnourished children is shown to improve environmental enteropathy. Severe malnourishment is also likely associated with microbiota immaturity, which might increase environmental enteropathy.

The intestinal mucosa turnover is dynamic, nutrient-dependent and rapid, and malnourished children have rate-limiting stores for repairing mucosal damage. The nutrients known to contribute to intestinal regeneration and improved barrier function are sulphur containing amino acids, glutamine, vitamin A and zinc.

Meanwhile, studies investigating associations between glutamine or vitamin A supplementation, serum retinol or zinc supplementation either alone, in combination with vitamin A or with micronutrients and antibiotics and environmental enteropathy show mixed results. Gut barrier repair and gut function may also be improved by a reduction in the inflammatory response.

Short-chain fatty acids (SCFA) result from fermentation of non starch polysaccharides in the colon. It is likely that short-chain fatty acids in addition to zinc and polyunsaturated fatty acids (PUFAs) may reduce gastrointestinal inflammation.

Although neither fibre nor polyunsaturated fatty acids provided as supplements improved lactulose:mannitol (L:M) ratio or inflammation in intervention trials, an increased protein and fibre intake from legumes as complementary food, might improve environmental enteropathy. Cessation of breastfeeding and introduction of complementary foods, especially foods with high fibre and protein content, also likely increases microbiota diversity, which might benefit the intestine.

As for micronutrient intake and environmental enteropathy, studies from Africa have demonstrated that multiple micronutrient supplementation may improve lactulose:mannitol (L:M) ratio in adults, and transiently in children. Finally, despite the diverse roles attributed to zinc in environmental enteropathy the effect of supplementation as prophylaxis is uncertain.

This may partly be due to the perturbed nutrient metabolism occurring in environmental enteropathy.

Research initiatives

There are multiple large-field, multi-country research initiatives focusing on strategies to prevent and treat EE. The MAL-ED project The Bangladesh Environmental Enteric Dysfunction (BEED) Study (ClinicalTrials.gov Identifier: NCT02812615) The Study of Environmental Enteropathy and Malnutrition (SEEM) in Pakistan (ClinicalTrials.gov Identifier: NCT03588013) The Alive and Thrive nutrition project The Sanitation, Hygiene and Infant Nutrition Efficacy (SHINE) Trial (ClinicalTrials.gov identifier: NCT01824940) The WASH Benefits Study

Text derived from https://en.wikipedia.org/w/index.php?oldid=1369099647 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.